FP&A Principal Analyst, Drug Substance Finance

Joining Moderna offers the unique opportunity to be part of a pioneering team that's revolutionizing medicine through mRNA technology, with a diverse pipeline of development programs across various diseases. As an employee, you'll be part of a continually growing organization, working alongside exceptional colleagues and strategic partners worldwide, contributing to global health initiatives. Moderna's commitment to advancing the technological frontier of mRNA medicines ensures a challenging and rewarding career experience, with the potential to make a significant impact on patients' lives worldwide. Moderna is solidifying its presence within our international business services hub in Warsaw, Poland, a city renowned for its rich scientific and technological heritage. This hub provides critical functions, meeting the growing demand of Moderna’s global business operations. We're inviting professionals from around the world to join our mission and contribute to the future of mRNA medicines. As Principal Analyst, Drug Substance Finance, you will play a pivotal role in enabling financial clarity and strategic insight across Moderna’s internal manufacturing footprint for Drug Substance operations, overseeing approximately $0.6 billion in associated spend. With deep exposure to internal manufacturing operations and raw materials procurement, this role is central to ensuring fiscal precision, strategic alignment, and continuous improvement in a high-impact biomanufacturing environment. Based in Warsaw and functioning as an individual contributor, you will collaborate closely with the Global Drug Substance Operations team to manage site-level budgets, enhance analytics, and drive financial efficiency. Your work will shape how financial decisions are made at scale, including the costing of new programs, materials, and operational scenarios—all while helping Moderna push the boundaries of digital finance and operational excellence.